首页> 外文会议>IEEE International Conference on Bioinformatics and Biomedicine >Radiomics for Predicting CyberKnife response in acoustic neuroma: a pilot study
【24h】

Radiomics for Predicting CyberKnife response in acoustic neuroma: a pilot study

机译:用于预测听神经瘤中射波刀反应的放射性药物:一项初步研究

获取原文

摘要

Vestibular schwannomas, also known as acoustic neuromas, are a primary intracranial tumor of the myelin-forming cells of the 8th cranial nerve. Stereotactic radiosurgery, which can be performed with the CyberKnife robotic device, is one of the approaches for managing this disease, and has shown to be effective in controlling tumor growth. However, it may have side effects and up to two years may be needed to assess its efficacy. In this work we present a machine learning-based radiomics approach that first computes quantitative biomarkers from MR images routinely collected before the CyberKnife treatment and then predicts the treatment response. Furthermore, the degree of class imbalance observed in the available dataset suggested us to resample the data during the learning stage. The results achieved are promising, with an accuracy equal to 85.3%.
机译:前庭神经鞘瘤,也称为听神经瘤,是8型髓鞘形成细胞的原发性颅内肿瘤。 颅神经。可以使用Cyber​​Knife机器人设备执行的立体定向放射外科手术是控制该疾病的方法之一,并且已证明可有效控制肿瘤的生长。但是,它可能有副作用,可能需要长达两年的时间才能评估其疗效。在这项工作中,我们提出了一种基于机器学习的放射学方法,该方法首先从在射波刀治疗之前常规收集的MR图像计算定量生物标志物,然后预测治疗反应。此外,在可用数据集中观察到的班级不平衡程度建议我们在学习阶段对数据进行重新采样。获得的结果令人鼓舞,准确度等于85.3%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号